Hemab Therapeutics Holdings, Inc. (COAG) Gross margin
Hemab Therapeutics Holdings, Inc. (COAG) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to COAGSource: SEC XBRL filings · For reference only · Not investment advice
More COAG financial trends
COAG RevenueCOAG Net incomeCOAG Net marginCOAG Gross profitCOAG Operating incomeCOAG Operating marginCOAG Operating cash flowCOAG Free cash flowCOAG Capital expendituresCOAG Return on equityCOAG Stock buybacksCOAG Dividends paidCOAG Total assetsCOAG Total liabilitiesCOAG Shareholders’ equityCOAG overview →